Susan E. Nozell, Ph.D.
Affiliations: | 2001 | Medical College of Georgia, Augusta, GA, United States |
Area:
Visual AttentionGoogle:
"Susan Nozell"Mean distance: 16.21 (cluster 29) | S | N | B | C | P |
Parents
Sign in to add mentor| Xin Chen | grad student | 2001 | Medical College of Georgia | |
| (p21B, a variant of p21(WAF1/Cip1), is induced by the p53 family.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Boyd NH, Walker K, Fried J, et al. (2017) Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo. Jci Insight. 2 |
| Lai YJ, Tsai JC, Tseng YT, et al. (2017) Small G protein Rac GTPases regulate the maintenance of glioblastoma stem-like cells in vitro and in vivo. Oncotarget |
| Rajbhandari R, McFarland BC, Patel A, et al. (2015) Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma Oncotarget. 6: 17805-17816 |
| McFarland BC, Hong SW, Rajbhandari R, et al. (2013) NF-κB-induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma. Plos One. 8: e78728 |
| McFarland BC, Ma JY, Langford CP, et al. (2011) Therapeutic potential of AZD1480 for the treatment of human glioblastoma. Molecular Cancer Therapeutics. 10: 2384-93 |
| Zhao X, Laver T, Hong SW, et al. (2011) An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomas. Journal of Neuro-Oncology. 102: 367-81 |
| Atkinson GP, Nozell SE, Harrison DK, et al. (2009) The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma. Oncogene. 28: 3735-45 |
| Nozell S, Laver T, Moseley D, et al. (2008) The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes. Molecular and Cellular Biology. 28: 6632-45 |
| Liu G, Nozell S, Xiao H, et al. (2004) DeltaNp73beta is active in transactivation and growth suppression. Molecular and Cellular Biology. 24: 487-501 |
| Nozell S, Wu Y, McNaughton K, et al. (2003) Characterization of p73 functional domains necessary for transactivation and growth suppression. Oncogene. 22: 4333-47 |